1. La Naissance du langage politique moderne: l'héritage des Lumières de Filangieri à Constant. Par Antonio Trampus. Issue 1 (19th November 2018) Authors: Rowe, Paul Journal: French studies Issue: Volume 73:Issue 1(2019) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Portrait de l'artiste en fille de joie: la littérature publique. Par Éléonore Reverzy. Issue 1 (25th October 2017) Authors: Rowe, Paul Journal: French studies Issue: Volume 72:Issue 1(2018) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Les Modes de sociabilité au château de Coppet à l'époque de Germaine de Staël (1766–1817). Par Martina Priebe. Issue 3 (19th June 2018) Authors: Rowe, Paul Journal: French studies Issue: Volume 72:Issue 3(2018) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma. (January 2022) Authors: Bateman, Eric D.; Khan, Asif H.; Xu, Yingxin; Guyot, Patricia; Chao, Jingdong; Kamat, Siddhesh; Rowe, Paul; Burnett, Heather; Msihid, Jerome; Weinreich, David; Pavord, Ian D. Journal: Respiratory medicine Issue: Volume 191(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020). (January 2022) Authors: Bateman, Eric D.; Khan, Asif H.; Xu, Yingxin; Guyot, Patricia; Chao, Jingdong; Kamat, Siddhesh; Rowe, Paul; Burnett, Heather; Msihid, Jerome; Weinreich, David M.; Pavord, Ian D. Journal: Respiratory medicine Issue: Volume 191(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma". (January 2022) Authors: Bateman, Eric D.; Khan, Asif H.; Xu, Yingxin; Guyot, Patricia; Chao, Jingdong; Kamat, Siddhesh; Rowe, Paul; Burnett, Heather; Msihid, Jerome; Weinreich, David; Pavord, Ian D. Journal: Respiratory medicine Issue: Volume 191(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. What are the most effective pharmacologic treatments for hirsutism in women?. Issue 3 (March 2020) Authors: Schuler, Cynthia; Rowe, Paul; Stavropoulos, Alexia; Thiry, Steven Journal: Evidence-based practice Issue: Volume 23:Issue 3(2020) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan. (23rd November 2020) Authors: Fujieda, Shigeharu; Matsune, Shoji; Takeno, Sachio; Asako, Mikiya; Takeuchi, Makiko; Fujita, Hiroyuki; Takahashi, Yoshinori; Amin, Nikhil; Deniz, Yamo; Rowe, Paul; Mannent, Leda Journal: Laryngoscope Issue: Volume 131:Number 6(2021) Page Start: E1770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Improvement in patient‐reported "taste" and association with smell in dupilumab‐treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS‐24 and SINUS‐52 trials. Issue 9 (12th July 2022) Authors: Peters, Anju T.; Soler, Zachary M.; Kern, Robert C.; Heffler, Enrico; Maspero, Jorge F.; Crampette, Louis; Fujieda, Shigeharu; Lane, Andrew P.; Zhang, Haixin; Nash, Scott; Khan, Asif H.; Siddiqui, Shahid; Jacob‐Nara, Juby A.; Rowe, Paul; Deniz, Yamo Journal: Clinical & experimental allergy Issue: Volume 52:Issue 9(2022) Page Start: 1105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline. Issue 1 (21st October 2020) Authors: Bourdin, Arnaud; Papi, Alberto A.; Corren, Jonathan; Virchow, J. Christian; Rice, Megan S.; Deniz, Yamo; Djandji, Michel; Rowe, Paul; Pavord, Ian D. Journal: Allergy Issue: Volume 76:Issue 1(2021) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗